DK1204662T3 - Azaindoler med serotoninreceptoraffinitet - Google Patents

Azaindoler med serotoninreceptoraffinitet

Info

Publication number
DK1204662T3
DK1204662T3 DK00949846T DK00949846T DK1204662T3 DK 1204662 T3 DK1204662 T3 DK 1204662T3 DK 00949846 T DK00949846 T DK 00949846T DK 00949846 T DK00949846 T DK 00949846T DK 1204662 T3 DK1204662 T3 DK 1204662T3
Authority
DK
Denmark
Prior art keywords
group
formula
azaindoles
double bond
serotonin receptor
Prior art date
Application number
DK00949846T
Other languages
Danish (da)
English (en)
Inventor
Ashok Tehim
Louise Edwards
Abdelmalik Slassi
Tao Xin
Original Assignee
Nps Allelix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Allelix Corp filed Critical Nps Allelix Corp
Application granted granted Critical
Publication of DK1204662T3 publication Critical patent/DK1204662T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
DK00949846T 1999-08-12 2000-08-14 Azaindoler med serotoninreceptoraffinitet DK1204662T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14834399P 1999-08-12 1999-08-12

Publications (1)

Publication Number Publication Date
DK1204662T3 true DK1204662T3 (da) 2004-10-04

Family

ID=22525363

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00949846T DK1204662T3 (da) 1999-08-12 2000-08-14 Azaindoler med serotoninreceptoraffinitet

Country Status (10)

Country Link
EP (1) EP1204662B1 (fr)
JP (1) JP4969004B2 (fr)
AT (1) ATE268330T1 (fr)
AU (1) AU779832B2 (fr)
CA (1) CA2382247C (fr)
DE (1) DE60011269T2 (fr)
DK (1) DK1204662T3 (fr)
ES (1) ES2222219T3 (fr)
MX (1) MXPA02001473A (fr)
WO (1) WO2001012629A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10030037A1 (de) 2000-06-17 2001-12-20 Mann & Hummel Filter Zylindrische Filterpatrone mit Stützrohr
ITRM20010356A1 (it) * 2001-06-21 2002-12-23 Sigma Tau Ind Farmaceuti "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
TW200301251A (en) 2001-12-20 2003-07-01 Wyeth Corp Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
ATE335477T1 (de) * 2001-12-20 2006-09-15 Wyeth Corp Indolylalkylamin-derivate als 5-hydroxytryptamin- 6 liganden
GB0202679D0 (en) * 2002-02-05 2002-03-20 Glaxo Group Ltd Novel compounds
WO2003080608A2 (fr) * 2002-03-27 2003-10-02 Glaxo Group Limited Composes
UA78999C2 (en) * 2002-06-04 2007-05-10 Wyeth Corp 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
EP1897881A3 (fr) 2002-06-20 2009-03-18 Biovitrum AB (publ) Composés utiles pour le traitement de l'obésité, du diabète de type II et des troubles du système nerveux central
TW200403243A (en) 2002-07-18 2004-03-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
CA2514656A1 (fr) * 2003-01-31 2004-08-12 Pfizer Products Inc. Antagonistes 5ht7 et agonistes inverses
WO2004074286A1 (fr) * 2003-02-14 2004-09-02 Wyeth Derives de heterocyclyl-3-sulfonylazaindole ou -azaindazole utilises comme ligands de la 5-hydroxytryptamine-6
WO2005009996A1 (fr) * 2003-07-23 2005-02-03 Wyeth Composes de sulfonyldihydrobenzimidazolone en tant que ligands de 5-hydroxytryptamine-6
ES2222828B1 (es) 2003-07-30 2006-04-16 Laboratorios Del Dr. Esteve, S.A. Derivados de 1-sulfonilindoles, su preparacion y su aplicacion como medicamentos.
EP1984351A1 (fr) 2006-02-17 2008-10-29 Memory Pharmaceuticals Corporation Composes ayant une affinite pour le recepteur 5-ht6
CA2655694C (fr) * 2006-07-03 2014-12-16 Biovitrum Ab (Publ) 1,4-indoles substitues utiles pour la modulation du recepteur de 5-ht6
JP2014515368A (ja) * 2011-05-26 2014-06-30 第一三共株式会社 プロテインキナーゼ阻害剤としての複素環化合物
EP3083588B1 (fr) 2013-12-20 2020-12-09 Sunshine Lake Pharma Co., Ltd. Composés hétérocycliques aromatiques et leur utilisation dans les produits pharmaceutiques
EP3166924B1 (fr) 2014-07-08 2019-02-20 Sunshine Lake Pharma Co., Ltd. Dérivés hétérocycliques aromatiques et leurs applications pharmaceutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9406128A (pt) * 1993-03-01 1996-02-27 Merck Sharp & Dohme Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica
US5846982A (en) * 1996-06-14 1998-12-08 Eli Lilly And Company Inhibition of serotonin reuptake
EP0875513A1 (fr) * 1997-04-14 1998-11-04 Eli Lilly And Company Composés hétéroaromatiques substitués agonistes du récepteur 5-HT1F
US5905084A (en) * 1997-11-14 1999-05-18 Eli Lilly And Company 5-HTIF -agonists effective in treating migraine
US6562809B1 (en) * 1998-09-18 2003-05-13 Nps Allelix Corp. 3-bicycloindole compounds

Also Published As

Publication number Publication date
ES2222219T3 (es) 2005-02-01
JP2003507380A (ja) 2003-02-25
JP4969004B2 (ja) 2012-07-04
MXPA02001473A (es) 2003-07-21
EP1204662B1 (fr) 2004-06-02
WO2001012629A1 (fr) 2001-02-22
AU779832B2 (en) 2005-02-10
EP1204662A1 (fr) 2002-05-15
CA2382247A1 (fr) 2001-02-22
AU6310300A (en) 2001-03-13
ATE268330T1 (de) 2004-06-15
DE60011269T2 (de) 2005-06-23
CA2382247C (fr) 2010-09-28
DE60011269D1 (de) 2004-07-08

Similar Documents

Publication Publication Date Title
DK1204662T3 (da) Azaindoler med serotoninreceptoraffinitet
IL110091A (en) POLYSUBSTITUTED IMIDAZO £4, 5-c| PYRIDIN-4-AMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR0315405A (pt) Compostos inibidores da integrase tricìclica pré-organizados
AR057023A1 (es) Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
CO5721006A2 (es) Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa
BR0010391A (pt) Composto, composição farmacêutica, método de preparação de um composto, e, uso de um composto
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
ATE227719T1 (de) Heteroaryl-zyklische acetale
DK584886A (da) Vanduoploeselige, mono- og disubstituerede derivater af rapamycin og farmaceutisk acceptable salte deraf
BR9914370A (pt) Derivados de tetraidrobenzazepina úteis comomoduladores de receptores para a dopamina d3(agentes antipsicóticos)
ES2176311T3 (es) Nuevos derivados imidazol y procedimiento para su preparacion.
ATE94061T1 (de) Arylsubstituierte aminderivate verwendbar in der krebstherapie.
EA200000400A1 (ru) Галогензамещенные тетрациклические производные тетрагидрофурана
TW200612920A (en) Novel imidazolidine derivatives
MX9205207A (es) Derivados de dihidropiridina, procedimiento para su preparacion y composicion farmaceutica que los comprende
CA2316388A1 (fr) Derive de tetrahydrobenzindole
FI884088A0 (fi) Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat.
AR027454A1 (es) Derivados de beta-alanina, utiles como antagonistas de receptores, las composiciones farmaceuticas que las contienen y el uso de los mismos para lapreparacion de medicamentos
MXPA04001171A (es) Compuestos policiclicos condensados.
DK1163258T3 (da) Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis
NO955071D0 (no) abeo-Ergolin-derivater som 5HT1A-ligander
DK0582506T3 (da) Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse af disse
DK602383A (da) 1,1-diphenylpropanolderivater
GB0114699D0 (en) Organic compounds
MY142362A (en) Pharmaceutical composition for promoting angiogenesis